| 1 |
Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries |
|
|
| Abdulaziz Ibrahim Alzarea, Yusra Habib Khan, Abdullah Salah Alanazi, Muhammad Hammad Butt, Ziyad Saeed Almalki, Abdullah K. AlAhmari, Saud Alsahali, Tauqeer Hussain Mallhi |
|
| International Journal of Environmental Research and Public Health. 2022; 19(13): 7862 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Spinal Muscular Atrophy Therapeutics in India: Parental Hopes and Despair! |
|
|
| Renu Suthar, Amol N Patil |
|
| Annals of Neurosciences. 2021; : 0972753121 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Health economics and effectiveness analysis of generic anti-diabetic medication from jan aushadhi: An ambispective study in community pharmacy |
|
|
| Raushan Kumar Chaudhary,Melwin Johns Philip,Ashly Santhosh,Satish S. Karoli,Ramesh Bhandari,M.S. Ganachari |
|
| Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021; 15(6): 102303 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Assessing the Application of Pharmacoeconomic Evaluations in Medicines Management by Hospital Pharmacists in Nigeria: A Cross-Sectional Survey |
|
|
| Theophilus Ehidiamen Oamen, Kanayo Patrick Osemene, Romanus Maduabuchi Ihekoronye |
|
| Hospital Topics. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patientsImpact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients |
|
|
| BhavyaH Vyas,NishitaH Darji,DevangA Rana,KaushalY Vyas,SupriyaD Malhotra |
|
| Perspectives in Clinical Research. 2021; 12(2): 76 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
A retrospective cross-sectional descriptive study to critically appraise the quality of reporting of health economic evaluations conducted in the Indian setting |
|
|
| SandeepKumar Gupta,RaviKant Tiwari,RajKumar Goel |
|
| Perspectives in Clinical Research. 2021; 0(0): 0 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings |
|
|
| Kamal Sharma, A B Chandorkar, Rajiv Kovil , S Venkataraman , KAV Subrahmanyam , Parthasarathi Mandal , Jasjeet Wasir , Mahesh Abhyankar, Ashish Prasad , Prashant S Sarda |
|
| Cureus. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
COST ANALYSIS OF DISEASE MODIFYING ANTI RHEUMATIC DRUGS: THE INDIAN SCENARIO |
|
|
| Zarrin Ansari,Sharmada Nerlekar,Sagar Karia,Sudhir Pawar |
|
| GLOBAL JOURNAL FOR RESEARCH ANALYSIS. 2020; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Assessment of the quality and trend of reporting of health economic evaluation research in India |
|
|
| Sonali Karekar,Yashashri Shetty |
|
| Expert Review of Pharmacoeconomics & Outcomes Research. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Urgency of the Implementation of Health Technology Assessment to Support Indonesian National Health Security System |
|
|
| Gunawan Widjaja,Hotmaria H. Sijabat |
|
| IOP Conference Series: Materials Science and Engineering. 2019; 508: 012144 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Knowledge Assessment of E-Bug Assisted Antimicrobial Resistance Education Module in Class VII School Students of South Indian Coastal Town of Manipal |
|
|
| Reona Fernandes,Swathi Naik,Archana-Gururaj Bhat,Rashmi Shetty,Manjunatha-H Hande,Abdul Ghafur,Mahadev Rao,Vijayanarayana Kunhikatta,John-Preshanth-Kumar Pathiraj |
|
| Journal of Clinical Medicine. 2019; 8(1): 84 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Evaluation and Characterization of Health Economics and Outcomes Research in SAARC Nations |
|
|
| Manthan Mehta,Rajan Nerurkar |
|
| Therapeutic Innovation & Regulatory Science. 2018; 52(3): 348 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
